The Blood Pressure Breakthrough: Mineralys Therapeutics’ Lorundrostat Shows Promise in Treating Uncontrolled Hypertension
In a major breakthrough for the medical community, Mineralys Therapeutics has announced positive topline results from its pivotal Launch-HTN and Advance-HTN trials evaluating the efficacy and safety of lorundrostat for treating uncontrolled hypertension (uHTN) or resistant hypertension (rHTN). The company’s…
Read More Now
Redfin Soars on $1.75 Billion Acquisition by Rocket Companies
In a move that’s sending shockwaves through the real estate industry, Redfin (RDFN) has announced it will be acquired by Rocket Companies in an all-stock deal worth $1.75 billion. The acquisition values Redfin at $12.50 per share, representing a whopping…
Read More Now
Big gains on breakthrough trial results and mega mergers
*sponsored by Blossom Social Good day, 360! Here are some of our top movers today. And don’t forget to join us in Market Masters – the hottest trading room around 🔥. PLUS»» Pre-Market Analysis Meets Opportunity = Market Navigator. …
Read More Now
The Hottest Trading Ideas
-->
